12/16/2024 | Press release | Distributed by Public on 12/16/2024 15:41
(in millions, except per share data) |
Three Months Ended Sept. 30, 2024 |
Fiscal Year Ended Sept. 30, 2024 |
||
Revenue | $ | 208.8 | $ | 1,117.4 |
Operating loss | (29.8) | (116.8) | ||
Adjusted operating (loss) earnings*
|
(12.8) | 93.2 | ||
Adjusted EBITDA*
|
15.6 | 206.3 | ||
Net loss | (48.3) | (206.1) | ||
Net (loss) earnings per diluted share | (1.17) | (4.99) | ||
Adjusted net (loss) earnings*
|
(31.5) | 3.7 | ||
Adjusted net (loss) earnings* per diluted share
|
$ | (0.77) | $ | 0.08 |
Salt Segment Range of Outcomes | |
2025 Range1
|
|
Highway deicing sales volumes (thousands of tons)
|
7,800 - 8,700 |
Consumer and industrial sales volumes (thousands of tons)
|
1,850 - 2,000 |
Total salt sales volumes (thousands of tons)
|
9,650 - 10,700 |
Revenue (in millions)
|
$940 - $1,040 |
Adj. EBITDA (in millions)
|
$225 - $250 |
Plant Nutrition Segment Guidance | |
2025 Range
|
|
Sales volumes (thousands of tons)
|
285 - 305 |
Revenue (in millions)
|
$175 - $195 |
Adj. EBITDA (in millions)
|
$14 - $20 |
Corporate | |
2025 Range
|
|
Total1
|
|
Adj. EBITDA (in millions)
|
($70) - ($61) |
Total Compass Minerals | ||||
2025 Adjusted EBITDA
|
||||
Salt | Plant Nutrition |
Corporate1
|
Total
|
|
Adj. EBITDA (in millions)
|
$225 - $250 | $14 - $20 | ($70) - ($61) | $169 - $209 |
2025 Capital Expenditures
|
||||
Total
|
||||
Capital expenditures (in millions)
|
$100 - $110 |
Other Assumptions | |
($ in millions) |
2025 Range
|
Depreciation, depletion and amortization | $105 - $115 |
Interest expense, net | $67 - $72 |
Effective income tax rate (excl. valuation allowance) | (295%) - (290%) |
Investor Contact | Media Contact |
Brent Collins | Rick Axthelm |
Vice President, Treasurer & Investor Relations | Chief Public Affairs and Sustainability Officer |
+1.913.344.9111 | +1.913.344.9198 |
[email protected] | [email protected] |
Special Items Impacting the Three Months Ended Sept. 30, 2024
(unaudited, in millions, except per share data)
|
||||||||||
Item Description | Segment | Line Item | Amount |
Tax Effect(1)
|
After Tax | EPS Impact | ||||
Restructuring charges(2)
|
Corporate and Other | Other operating expense | $ | (1.4) | $ | - | $ | (1.4) | $ | (0.04) |
Impairments | Plant Nutrition | Loss on impairments | 17.6 | - | 17.6 | 0.43 | ||||
Provision for product recall costs
|
Salt | Other operating expense | 0.8 | (0.2) | 0.6 | 0.01 | ||||
Total | $ | 17.0 | $ | (0.2) | $ | 16.8 | $ | 0.40 |
Special Items Impacting the Three Months Ended Sept. 30, 2023
(unaudited, in millions, except per share data)
|
||||||||||
Item Description | Segment | Line Item | Amount |
Tax Effect(1)
|
After Tax | EPS Impact | ||||
Accrued legal costs related to SEC investigation | Corporate and Other | Other operating expense | $ | (0.2) | $ | - | $ | (0.2) | $ | - |
Special Items Impacting the Fiscal Year Ended Sept. 30, 2024
(unaudited, in millions, except per share data)
|
||||||||||
Item Description | Segment | Line Item | Amount |
Tax Effect(1)
|
After Tax | EPS Impact | ||||
Restructuring charges(2)
|
Corporate and Other | Other operating expense | $ | 14.8 | $ | - | $ | 14.8 | $ | 0.36 |
Restructuring charges(2)
|
Salt | Other operating expense | 0.4 | - | 0.4 | 0.01 | ||||
Restructuring charges(2)
|
Plant Nutrition | Other operating expense | 0.6 | - | 0.6 | 0.01 | ||||
Impairments | Corporate and Other | COGS and Loss on impairments | 124.8 | 124.8 | 3.02 | |||||
Impairments | Plant Nutrition | Loss on impairments | 68.6 | - | 68.6 | 1.66 | ||||
Provision for product recall costs
|
Salt | Other operating expense | 0.8 | (0.2) | 0.6 | 0.01 | ||||
Total | $ | 210.0 | $ | (0.2) | $ | 209.8 | $ | 5.07 |
Special Items Impacting the Fiscal Year Ended Sept. 30, 2023
(unaudited, in millions, except per share data)
|
||||||||||
Item Description | Segment | Line Item | Amount |
Tax Effect(1)
|
After Tax | EPS Impact | ||||
Restructuring charges | Corporate and Other | Other operating expense | $ | 2.6 | $ | - | $ | 2.6 | $ | 0.07 |
Restructuring charges | Salt | COGS and other operating expense | 1.5 | (0.1) | 1.4 | 0.04 | ||||
Restructuring charges | Plant Nutrition | COGS and other operating expense | 1.4 | - | 1.4 | 0.03 | ||||
Accrued legal costs related to SEC investigation | Corporate and Other | Other operating expense | (0.3) | - | (0.3) | (0.01) | ||||
Total | $ | 5.2 | $ | (0.1) | $ | 5.1 | $ | 0.13 |
Reconciliation for Adjusted Operating (Loss) Earnings
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Operating (loss) earnings | $ | (29.8) | $ | 2.2 | $ | (116.8) | $ | 77.4 |
Restructuring charges(1)
|
(1.4) | - | 15.8 | 5.5 | ||||
Loss on impairments(2)
|
17.6 | - | 193.4 | - | ||||
Provision for product recall costs(3)
|
0.8 | - | 0.8 | - | ||||
Accrued loss and legal costs related to SEC investigation(4)
|
- | (0.2) | - | (0.3) | ||||
Adjusted operating (loss) earnings | $ | (12.8) | $ | 2.0 | $ | 93.2 | $ | 82.6 |
Sales | 208.8 | 233.6 | 1,117.4 | 1,204.7 | ||||
Operating margin | (14.3) | % | 0.9 | % | (10.5) | % | 6.4 | % |
Adjusted operating margin | (6.1) | % | 0.9 | % | 8.3 | % | 6.9 | % |
Reconciliation for Adjusted Net (Loss) Earnings
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Net (loss) earnings | $ | (48.3) | $ | (4.0) | $ | (206.1) | $ | 10.5 |
Restructuring charges(1)
|
(1.4) | - | 15.8 | 5.5 | ||||
Loss on impairments(2)
|
17.6 | - | 193.4 | - | ||||
Provision for product recall costs(3)
|
0.8 | - | 0.8 | - | ||||
Accrued loss and legal costs related to SEC investigation(4)
|
- | (0.2) | - | (0.3) | ||||
Income tax effect | (0.2) | - | (0.2) | (0.1) | ||||
Adjusted net (loss) earnings | $ | (31.5) | $ | (4.2) | $ | 3.7 | $ | 15.6 |
Diluted net (loss) earnings per common share | $ | (1.17) | $ | (0.10) | $ | (4.99) | $ | 0.25 |
Adjusted net (loss) earnings per diluted share | $ | (0.77) | $ | (0.10) | $ | 0.08 | $ | 0.38 |
Weighted-average common shares outstanding (in thousands): | ||||||||
Diluted | 41,369 | 41,152 | 41,306 | 40,786 |
Reconciliation for EBITDA and Adjusted EBITDA
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Net (loss) earnings | $ | (48.3) | $ | (4.0) | $ | (206.1) | $ | 10.5 |
Interest expense | 19.1 | 13.1 | 69.5 | 55.5 | ||||
Income tax (benefit) expense | (2.5) | (7.1) | 17.9 | 17.1 | ||||
Depreciation, depletion and amortization | 26.6 | 25.9 | 105.0 | 98.6 | ||||
EBITDA | (5.1) | 27.9 | (13.7) | 181.7 | ||||
Adjustments to EBITDA: | ||||||||
Stock-based compensation - non cash | 1.8 | 3.4 | 8.1 | 20.6 | ||||
Interest income | (0.2) | (0.6) | (1.0) | (5.3) | ||||
Loss (gain) on foreign exchange | 1.8 | (2.3) | 0.7 | 2.3 | ||||
Loss (gain) from remeasurement of equity method investment | - | 2.5 | - | (10.1) | ||||
Restructuring charges(1)
|
(1.4) | - | 15.8 | 5.9 | ||||
Loss on impairments(2)
|
17.6 | - | 193.4 | - | ||||
Provision for product recall costs(3)
|
0.8 | - | 0.8 | - | ||||
Accrued loss and legal costs related to SEC investigation(4)
|
- | (0.2) | - | (0.3) | ||||
Other, net | 0.3 | 0.6 | 2.2 | 4.3 | ||||
Adjusted EBITDA | 15.6 | 31.3 | 206.3 | 199.1 |
Salt Segment Performance
(in millions, except for sales volumes and prices per short ton) |
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Sales | $ | 162.5 | $ | 186.7 | $ | 907.8 | $ | 1,010.8 |
Operating earnings | $ | 21.0 | $ | 28.6 | $ | 163.6 | $ | 170.5 |
Operating margin | 12.9 | % | 15.3 | % | 18.0 | % | 16.9 | % |
Adjusted operating earnings(1)
|
$ | 21.8 | $ | 28.6 | $ | 164.8 | $ | 172.0 |
Adjusted operating margin(1)
|
13.4 | % | 15.3 | % | 18.2 | % | 17.0 | % |
EBITDA(1)
|
$ | 37.3 | $ | 44.2 | $ | 227.0 | $ | 229.0 |
EBITDA(1) margin
|
23.0 | % | 23.7 | % | 25.0 | % | 22.7 | % |
Adjusted EBITDA(1)
|
$ | 38.1 | $ | 44.2 | $ | 228.2 | $ | 230.5 |
Adjusted EBITDA(1) margin
|
23.4 | % | 23.7 | % | 25.1 | % | 22.8 | % |
Sales volumes (in thousands of tons): | ||||||||
Highway deicing | 1,061 | 1,435 | 7,462 | 9,321 | ||||
Consumer and industrial | 449 | 470 | 1,852 | 1,999 | ||||
Total Salt | 1,510 | 1,905 | 9,314 | 11,320 | ||||
Average sales prices (per ton): | ||||||||
Highway deicing | $ | 70.98 | $ | 68.78 | $ | 73.23 | $ | 68.85 |
Consumer and industrial | $ | 194.41 | $ | 187.44 | $ | 195.14 | $ | 184.67 |
Total Salt | $ | 107.66 | $ | 98.03 | $ | 97.47 | $ | 89.29 |
Reconciliation for Salt Segment Adjusted Operating Earnings
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Reported GAAP segment operating earnings | $ | 21.0 | $ | 28.6 | $ | 163.6 | $ | 170.5 |
Restructuring charges(1)
|
- | - | 0.4 | 1.5 | ||||
Provision for product recall costs(2)
|
0.8 | - | 0.8 | - | ||||
Segment adjusted operating earnings | $ | 21.8 | $ | 28.6 | $ | 164.8 | $ | 172.0 |
Segment sales | 162.5 | 186.7 | 907.8 | 1,010.8 | ||||
Segment adjusted operating margin | 13.4 | % | 15.3 | % | 18.2 | % | 17.0 | % |
Reconciliation for Salt Segment EBITDA and Adjusted EBITDA
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Reported GAAP segment operating earnings | $ | 21.0 | $ | 28.6 | $ | 163.6 | $ | 170.5 |
Depreciation, depletion and amortization | 16.3 | 15.6 | 63.4 | 58.5 | ||||
Segment EBITDA | $ | 37.3 | $ | 44.2 | $ | 227.0 | $ | 229.0 |
Restructuring charges(1)
|
- | - | 0.4 | 1.5 | ||||
Provision for product recall costs(2)
|
0.8 | - | 0.8 | - | ||||
Segment adjusted EBITDA | $ | 38.1 | $ | 44.2 | $ | 228.2 | $ | 230.5 |
Segment sales | 162.5 | 186.7 | 907.8 | 1,010.8 | ||||
Segment adjusted EBITDA margin | 23.4 | % | 23.7 | % | 25.1 | % | 22.8 | % |
Plant Nutrition Segment Performance
(in millions, except for prices per short ton)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Sales | $ | 42.4 | $ | 35.3 | $ | 181.0 | $ | 172.1 |
Operating (loss) earnings | $ | (29.7) | $ | (3.3) | $ | (86.4) | $ | 9.5 |
Operating margin | (70.0) | % | (9.3) | % | (47.7) | % | 5.5 | % |
Adjusted operating (loss) earnings(1)
|
$ | (12.1) | $ | (3.3) | $ | (17.2) | $ | 10.9 |
Adjusted operating margin(1)
|
(28.5) | % | (9.3) | % | (9.5) | % | 6.3 | % |
EBITDA(1)
|
$ | (21.3) | $ | 5.0 | $ | (52.3) | $ | 42.4 |
EBITDA(1) margin
|
(50.2) | % | 14.2 | % | (28.9) | % | 24.6 | % |
Adjusted EBITDA(1)
|
$ | (3.7) | $ | 5.0 | $ | 16.9 | $ | 43.8 |
Adjusted EBITDA(1) margin
|
(8.7) | % | 14.2 | % | 9.3 | % | 25.5 | % |
Sales volumes (in thousands of tons) | 68 | 51 | 273 | 219 | ||||
Average sales price (per ton) | $ | 623 | $ | 691 | $ | 663 | $ | 785 |
Reconciliation for Plant Nutrition Segment Adjusted Operating Earnings
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Reported GAAP segment operating (loss) earnings | $ | (29.7) | $ | (3.3) | $ | (86.4) | $ | 9.5 |
Restructuring charges(1)
|
- | - | 0.6 | 1.4 | ||||
Loss on impairment(2)
|
17.6 | - | 68.6 | - | ||||
Segment adjusted operating (loss) earnings | $ | (12.1) | $ | (3.3) | $ | (17.2) | $ | 10.9 |
Segment sales | 42.4 | 35.3 | 181.0 | 172.1 | ||||
Segment adjusted operating margin | (28.5) | % | (9.3) | % | (9.5) | % | 6.3 | % |
Reconciliation for Plant Nutrition Segment EBITDA and Adjusted EBITDA
(unaudited, in millions)
|
||||||||
Three months ended Sept. 30, |
Twelve months ended Sept. 30, |
|||||||
2024 | 2023 | 2024 | 2023 | |||||
Reported GAAP segment operating (loss) earnings | $ | (29.7) | $ | (3.3) | $ | (86.4) | $ | 9.5 |
Depreciation, depletion and amortization | 8.4 | 8.3 | 34.1 | 32.9 | ||||
Segment EBITDA | $ | (21.3) | $ | 5.0 | $ | (52.3) | $ | 42.4 |
Restructuring charges(1)
|
- | - | 0.6 | 1.4 | ||||
Loss on impairment(2)
|
17.6 | - | 68.6 | - | ||||
Segment Adjusted EBITDA | $ | (3.7) | $ | 5.0 | $ | 16.9 | $ | 43.8 |
Segment sales | 42.4 | 35.3 | 181.0 | 172.1 | ||||
Segment adjusted EBITDA margin | (8.7) | % | 14.2 | % | 9.3 | % | 25.5 | % |
Three Months Ended | Twelve Months Ended | |||||||
Sept. 30, | Sept. 30, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Sales | $ | 208.8 | $ | 233.6 | $ | 1,117.4 | $ | 1,204.7 |
Shipping and handling cost | 50.2 | 54.8 | 305.3 | 346.1 | ||||
Product cost | 139.1 | 136.6 | 617.1 | 626.6 | ||||
Gross profit | 19.5 | 42.2 | 195.0 | 232.0 | ||||
Selling, general and administrative expenses | 31.3 | 41.0 | 137.8 | 150.2 | ||||
Loss on impairments | 17.6 | - | 191.0 | - | ||||
Other operating expense (income) | 0.4 | (1.0) | (17.0) | 4.4 | ||||
Operating (loss) earnings | (29.8) | 2.2 | (116.8) | 77.4 | ||||
Other expense (income): | ||||||||
Interest income | (0.2) | (0.6) | (1.0) | (5.3) | ||||
Interest expense | 19.1 | 13.1 | 69.5 | 55.5 | ||||
Loss (gain) on foreign exchange | 1.8 | (2.3) | 0.7 | 2.3 | ||||
Net loss in equity investees | - | - | - | 3.1 | ||||
Loss (gain) from remeasurement of equity method investment | - | 2.5 | - | (10.1) | ||||
Other expense, net | 0.3 | 0.6 | 2.2 | 4.3 | ||||
Loss before income taxes | (50.8) | (11.1) | (188.2) | 27.6 | ||||
Income tax (benefit) expense | (2.5) | (7.1) | 17.9 | 17.1 | ||||
Net (loss) earnings | $ | (48.3) | $ | (4.0) | $ | (206.1) | $ | 10.5 |
Basic net (loss) earnings per common share | $ | (1.17) | $ | (0.10) | $ | (4.99) | $ | 0.25 |
Diluted net (loss) earnings per common share | $ | (1.17) | $ | (0.10) | $ | (4.99) | $ | 0.25 |
Cash dividends per share | $ | - | $ | 0.15 | $ | 0.30 | $ | 0.60 |
Weighted-average common shares outstanding (in thousands):(1)
|
||||||||
Basic | 41,369 | 41,152 | 41,306 | 40,786 | ||||
Diluted | 41,369 | 41,152 | 41,306 | 40,786 |
Sept. 30, | Sept. 30, | |||
2024 | 2023 | |||
ASSETS | ||||
Cash and cash equivalents | $ | 20.2 | $ | 38.7 |
Receivables, net | 126.1 | 129.3 | ||
Inventories, net | 414.1 | 399.5 | ||
Other current assets | 26.9 | 33.4 | ||
Property, plant and equipment, net | 806.5 | 852.5 | ||
Intangible and other noncurrent assets | 246.3 | 363.5 | ||
Total assets | $ | 1,640.1 | $ | 1,816.9 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current portion of long-term debt | $ | 7.5 | $ | 5.0 |
Other current liabilities | 209.5 | 269.6 | ||
Long-term debt, net of current portion | 910.0 | 800.3 | ||
Deferred income taxes and other noncurrent liabilities | 196.5 | 221.0 | ||
Total stockholders' equity | 316.6 | 521.0 | ||
Total liabilities and stockholders' equity | $ | 1,640.1 | $ | 1,816.9 |
COMPASS MINERALS INTERNATIONAL, INC. | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(unaudited, in millions) | ||||
Twelve Months Ended | ||||
Sept. 30, | ||||
2024 | 2023 | |||
Net cash provided by operating activities | $ | 14.4 | $ | 106.0 |
Cash flows from investing activities: | ||||
Capital expenditures | (114.2) | (154.3) | ||
Acquisition of business, net of cash acquired | - | (18.9) | ||
Other, net | (1.9) | (4.7) | ||
Net cash used in investing activities | (116.1) | (177.9) | ||
Cash flows from financing activities: | ||||
Proceeds from revolving credit facility borrowings | 422.8 | 150.0 | ||
Principal payments on revolving credit facility borrowings | (314.2) | (220.0) | ||
Proceeds from the issuance of long-term debt | 81.6 | 239.9 | ||
Principal payments on long-term debt | (78.6) | (314.6) | ||
Payments for contingent consideration | (9.1) | - | ||
Net proceeds from private placement of common stock | - | 240.7 | ||
Dividends paid | (12.6) | (24.9) | ||
Deferred financing costs | (2.1) | (3.9) | ||
Shares withheld to satisfy employee tax obligations | (2.1) | (1.7) | ||
Other, net | (2.6) | (1.5) | ||
Net cash provided by financing activities | 83.1 | 64.0 | ||
Effect of exchange rate changes on cash and cash equivalents | 0.1 | 0.5 | ||
Net change in cash and cash equivalents | (18.5) | (7.4) | ||
Cash and cash equivalents, beginning of the year | 38.7 | 46.1 | ||
Cash and cash equivalents of continuing operations, end of period | $ | 20.2 | $ | 38.7 |
Three Months Ended Sept. 30, 2024
|
Salt |
Plant Nutrition |
Corporate and Other(1)
|
Total |
||||
Sales to external customers | $ | 162.5 | $ | 42.4 | $ | 3.9 | $ | 208.8 |
Intersegment sales | - | 1.4 | (1.4) | - | ||||
Shipping and handling cost | 44.2 | 6.0 | - | 50.2 | ||||
Operating earnings (loss)(2)(3)(4)
|
21.0 | (29.7) | (21.1) | (29.8) | ||||
Depreciation, depletion and amortization | 16.3 | 8.4 | 1.9 | 26.6 | ||||
Total assets | 1,084.5 | 388.1 | 167.5 | 1,640.1 | ||||
Three Months Ended Sept. 30, 2023
|
Salt |
Plant Nutrition |
Corporate and Other(1)
|
Total |
||||
Sales to external customers | $ | 186.7 | $ | 35.3 | $ | 11.6 | $ | 233.6 |
Intersegment sales | - | 2.6 | (2.6) | - | ||||
Shipping and handling cost | 49.6 | 5.0 | 0.2 | 54.8 | ||||
Operating earnings (loss)(3)
|
28.6 | (3.3) | (23.1) | 2.2 | ||||
Depreciation, depletion and amortization | 15.6 | 8.3 | 2.0 | 25.9 | ||||
Total assets | 1,050.4 | 473.4 | 293.1 | 1,816.9 | ||||
Twelve Months Ended Sept. 30, 2024
|
Salt |
Plant Nutrition |
Corporate and Other(1)
|
Total |
||||
Sales to external customers | $ | 907.8 | $ | 181.0 | $ | 28.6 | $ | 1,117.4 |
Intersegment sales | - | 8.0 | (8.0) | - | ||||
Shipping and handling cost | 280.1 | 24.6 | 0.6 | 305.3 | ||||
Operating earnings (loss)(2)(3)(4)
|
163.6 | (86.4) | (194.0) | (116.8) | ||||
Depreciation, depletion and amortization | 63.4 | 34.1 | 7.5 | 105.0 | ||||
Twelve Months Ended Sept. 30, 2023
|
Salt |
Plant Nutrition |
Corporate and Other(1)
|
Total |
||||
Sales to external customers | $ | 1,010.8 | $ | 172.1 | $ | 21.8 | $ | 1,204.7 |
Intersegment sales | - | 9.7 | (9.7) | - | ||||
Shipping and handling cost | 324.5 | 21.4 | 0.2 | 346.1 | ||||
Operating earnings (loss)(3)(4)
|
170.5 | 9.5 | (102.6) | 77.4 | ||||
Depreciation, depletion and amortization | 58.5 | 32.9 | 7.2 | 98.6 |